Cellular & Molecular biology

#AI / data analytics / healthtech / informatics #Assay development optimisation & technology #Biochemistry #Business #Cell therapy #Cellular & Molecular biology #Cellular assays #Chemistry #Combinatorial chemistry #Drug development #Drug discovery #Drug targets #Gene therapy #Genetics / genomes #Genetics / genomics #Genomics #High Content Screening #Immunology #Lead discovery #Medicinal chemistry #Pathology #Pharmacology #Pharmokinetics #Preclinical #Protein chemistry / Proteomics #RNA #Sequencing #Stem cells #System biology #Systems biology #Target validation #Therapeutics

Discovery Research in the Co-Genomic Era – Biology goes industrial

Discovery Research in the Co-Genomic Era - Biology goes industrial By Dr Timothy Wells and Dr Georg Feger The parallel between the search for gold in the last century and drug discovery in the co-genome era is very clear. As with all gold rushes the rewards will go to the… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Animal models #Assay development & optimisation #Assay development optimisation & technology #Automation / robotics #Biochemistry #Biomarkers #Business #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Clinical trials #Combinatorial chemistry #Computational chemistry #Drug development #Drug discovery #Drug targets #Genetics / genomes #Genomics #High Content Screening #High throughput screening #In Silico Biology #Lead discovery #Lead optimisation #Medicinal chemistry #Molecular medicine #PCR #Preclinical #Protein chemistry / Proteomics #RNA #Screening #Sequencing #Stem cells #System biology #Systems biology #Target validation

Exploiting the fruits of the human genome – A strategic perspective

By Dr David C. U’Prichard It is almost axiomatic that the pharmaceutical R&D industry has not achieved in the last decade an increase in productivity (measured as high value NCEs) commensurate with the explosion of new biological information, chemistry techniques and information storage/retrieval/examination systems, let alone the real increase in… Read More

#Archive

Genome editing
#AI / data analytics / healthtech / informatics #Assay development optimisation & technology #Cellular & Molecular biology #Clinical trials #Drug development #Drug discovery #Genetics / genomes #Genetics / genomics #Genomics #Lead discovery #Molecular medicine #Preclinical #RNA #Sequencing #System biology #Systems biology #Toxicology

The role of toxicogenomics in drug discovery

The role of toxicogenomics in drug discovery By Dr Robin E. Neft and Dr Spencer Farr The information that toxicogenomics can bring in terms of toxic mechanisms, safety and efficacy must ultimately have a major impact on the drug discovery process. Large scale genome sequencing has lead to elucidation of… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Automation / robotics #Biochemistry #Biomarkers #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Drug development #Drug discovery #Drug targets #Enabling technologies #Genetics / genomes #Genomics #High throughput screening #Imaging #Lead discovery #Mass spectrometry / NMR #Pharmacology #Preclinical #Protein chemistry / Proteomics #Screening #Sequencing #Stem cells #Target validation #Translational #Translational chemistry

Proteomics – From a drug discovery perspective

By Dr Ashok R. Dongre and Dr Stanley A. Hefta The genomic sequencing efforts spawned the field of proteomics by providing the basic blueprint for protein sequences, enabling proteomics to become the contemporary technology for studying the underlying mechanisms of disease. This review will address the technologies related to proteomic… Read More

#Archive

Close up of vaccine syringe
#AI / data analytics / healthtech / informatics #Animal models #Cell / tissue culture #Cell culture #Cell therapy #Cellular & Molecular biology #Clinical trials #Gene therapy #Genetics / genomes #Immunology #Immunology / Virology & Vaccines #Oncology #Pharmacology #Preclinical #Protein chemistry / Proteomics #RNA #Stem cells

Emerging therapeutic vaccines

Emerging therapeutic vaccines By Marc Hertz, Soren Mouritsen and Anand Gautam The excitement over the past 30 years for immunotherapy of cancer and other diseases has not led to the expected clinical successes. Over-enthusiasts predicted a cure for cancer with the initial development of monoclonal antibody technology, and later the… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Automation / robotics #Business #Cellular & Molecular biology #Chemical engineering #Chemistry #Combinatorial chemistry #Drug development #Drug discovery #Drug targets #High throughput screening #Lead discovery #Lead optimisation #Mass spectrometry / NMR #Medicinal chemistry #RNA #Screening #Target validation

Recent Developments in Combinatorial Chemistry

Recent Developments in Combinatorial Chemistry By Dr Anthony D Baxter Combinatorial chemistry has advanced significantly from the early 1990s when it was a new science of mainly conceptual interest to today where it has evolved into a key component of the drug discovery industry. The needs of the Pharma industry… Read More

#Archive

High-throughput screening
#ADME / Tox #AI / data analytics / healthtech / informatics #Analysis #Analytical chemistry #Assay development & optimisation #Assay development optimisation & technology #Automation / robotics #Biochemistry #Business #Cellular & Molecular biology #Cellular assays #Chemistry #Combinatorial chemistry #Computational chemistry #Drug development #Drug discovery #Drug targets #Genomics #High Content Screening #High throughput screening #Imaging #Isotope labelling #Lead discovery #Lead optimisation #PCR #Pharmacology #Protein chemistry / Proteomics #RNA #Screening #Stem cells #Toxicology

HTS a strategy for drug discovery

HTS a strategy for drug discovery By Dr AR Knight, Cerebrus Ltd Whichever technologies are implemented, high throughput screening is set to become one of the cornerstones of drug discovery, however deciding which strategy to implement will provide many headaches. This article concentrates on screens identifying the interaction of small… Read More

#Archive

#AI / data analytics / healthtech / informatics #Analysis #Assay development optimisation & technology #Biochemistry #Business #Cellular & Molecular biology #Cellular assays #Drug development #Drug discovery #Drug targets #Genetics / genomes #Genomics #High Content Screening #High throughput screening #Immunology #Lead discovery #Mass spectrometry / NMR #Protein chemistry / Proteomics #RNA #Screening #Sequencing #Stem cells #Target validation #Translational #Translational chemistry #Urinary

Gene function via the analysis of multi-pro

By Matthias Mann, Protein Interaction Laboratory (PIL), University of Southern Denmark Affinity proteomic methods can translate genomic data into validated targets for drug discovery. Baits such as tagged gene product or small molecules obtained from cell-based assays are used to purify interacting proteins. These proteins are then identified by high… Read More

#Archive